Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
CADILA HEALTHCARE LIMITED	AHMEDABAD - 382481 GUJARAT

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C07D:HETEROCYCLIC COMPOUNDS

• 2015 Application Filing Year
• A61K Class
• 16157 Applications Filed
• 11882 Patents Issued To-Date
• 73.55 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Bahekar, Rajesh	Gujarat, IN	9	40
# of filed Patents : 9 Total Citations : 40
Desai, Ranjit C	Gujarat, IN	39	474
# of filed Patents : 39 Total Citations : 474
Patel, Dipam	Gujarat, IN	11	479
# of filed Patents : 11 Total Citations : 479
Shah, Kiran	Gujarat, IN	4	15
# of filed Patents : 4 Total Citations : 15

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 2 Citation Count
• A61K Class

• 45.09 % this patent is cited more than
• 8 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
7.5 Year Payment	$3600.00	$1800.00	$900.00	Jun 12, 2025
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Jun 12, 2029

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
December 12, 2017	US,9840509,B2   US9840509B2	GRANTED PATENT AS SECOND PUBLICATION
December 29, 2016	US,20160376277,A1   US20160376277A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9840509

Heterocyclic compounds

---

Abstract

---

The present invention relates to heterocyclic compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, and polymorphs. The invention also relates to processes for the preparation of the compounds of invention, pharmaceutical compositions containing the compounds and their use as selective Bruton's Tyrosine Kinase (BTK) inhibitors.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• STCH2022
• LAPS2022
• FP2021
• FEPP2021
• I2017
• PD2017
• STCF2017
• P2016
• AS2016
• F2015

Date	Code	Event	Description
Jan 17, 2022	STCH	INFORMATION ON STATUS: PATENT DISCONTINUATION	free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362
Jan 17, 2022	LAPS	LAPSE FOR FAILURE TO PAY MAINTENANCE FEES	free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY
Dec 12, 2021	FP	LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE	Effective Date: Dec 12, 2021
Aug 02, 2021	FEPP	FEE PAYMENT PROCEDURE	free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY
Dec 12, 2017	I	Issuance
Dec 12, 2017	PD	Priority Date
Nov 21, 2017	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Dec 29, 2016	P	Published
Jul 11, 2016	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DESAI, RANJIT C.;BAHEKAR, RAJESH;PATEL, DIPAM;AND OTHERS;REEL/FRAME:039188/0636 Owner name: CADILA HEALTHCARE LIMITED, INDIA Effective Date: Jul 11, 2016
Feb 02, 2015	F	Filing